Results 11 to 20 of about 48 (48)

Disputable Issues of Etiology and Pathogenesis of Tertiary Hyperparathyroidism

Acta Biomedica Scientifica, 2019
Hyperparathyroidism is a clinical and laboratory syndrome characterized by high production of the chief cells of the parathyroid hormone, a calcium-phosphorus metabolism disorder and the organ failure (kidneys, bone tissue).There are primary, secondary ...
G. A. Bersenev, E. A. Ilyicheva, D. A. Bulgatov   +2 more
doaj   +1 more source

PROGRAMMED APPROACH TO THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC RENAL DISEASE

Вестник хирургии имени И.И. Грекова, 2018
Prevalence and course of secondary hyperparathyroidism were studied in 616 patients with chronic renal disease. Disorders of mineral metabolism, which develop when person has chronic renal disease, appear at the early stage of the disease.
N. A. Samohvalova, N. A. Maystrenko, P. N. Romashchenko   +2 more
doaj   +1 more source

OSOBENNOSTI KOSTNOGO METABOLIZMA U BOL'NYKh S IDIOPATIChESKIM SKOLIOZOM (PREDVARITEL'NOE SOOBShchENIE)

Остеопороз и остеопатии, 2016
Ранее была показана связь генерализованной остеопении у пациентов с идиопатическим сколиозом с прогрессированием деформации позвоночника. Учитывая многофакторную модель развития сколиоза, предполагается, что остеопения может являться одним из ...
E N BAKhTINA, S S RODIONOVA, A A KULEShOV, S V KOLESOV   +3 more
doaj   +1 more source

[Primary hyperparathyroidism in children]. [PDF]

Probl Endokrinol (Mosk), 2023
Benina AR, Kolodkina AA, Tiul'pakov AN, Kalinchenko NY, Brovin DM, Anikiev AV, Danilenko OS, Sheremeta MS, Zakharova VV, Solodovnikova EN, Bezlepkina OB.   +10 more
europepmc   +1 more source

[Syndrome of hypocalсiuric hypercalcemia. Is it rare? Two clinical cases in an outpatient clinic]. [PDF]

Probl Endokrinol (Mosk), 2022
Sviridonova MA.
europepmc   +1 more source

[Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors]. [PDF]

Probl Endokrinol (Mosk), 2023
Voytko MS, Klimontov VV, Pospelova TI, Shebunyaeva YY, Fazullina ON.   +4 more
europepmc   +1 more source

[FGF23 tumor induced osteomalacia]. [PDF]

Probl Endokrinol (Mosk), 2022
Gronskaia SA, Belaya ZE, Melnichenko GA.
europepmc   +1 more source

[Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy]. [PDF]

Probl Endokrinol (Mosk), 2023
Maganeva IS, Bondarenko AS, Miliutina AP, Elfimova AR, Bibik EE, Nikankina LV, Tarbaeva NV, Eremkina AK, Mokrysheva NG.   +8 more
europepmc   +1 more source

[Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases]. [PDF]

Probl Endokrinol (Mosk), 2023
Gronskaia SA, Belaya ZE, Rozhinskaya LY, Melnichenko GA, Dubovitskaya TA, Mamedova EO, Rodionova SS, Buklemishev YV, Pigarova EA, Degtyarev MV, Babaeva DM, Vladimirova VP, Tarbaeva NV, Serzhenko SS, Grigoriev AY, Dzeranova LK, Karpenko VY, Karasev AL, Fedotov RN, Uliyanova IN, Toroptsova NV, Lesnyak OM, Mokrysheva NG, Dedov II.   +23 more
europepmc   +1 more source

[Corticotropin-producing pheochromocytoma in multiple endocrine neoplasia type 1]. [PDF]

Probl Endokrinol (Mosk), 2023
Rebrova DV, Grigorova SI, Vorokhobina NV, Zgoda EA, Novokshonov KY, Feofanova SG, Rusakov VF, Krasnov LM, Fedorov EA, Chinchuk IK, Shikhmagomedov SS, Pushkaruk AA, Sleptsov IV.   +12 more
europepmc   +1 more source